RoslinCT will manufacture the groundbreaking new gene therapy Casgevy (exagamglogene autotemcel) for sickle cell disease (SCD) patients…
Articles by Mary Chapman
A Phase 3 clinical trial evaluating whether adding red blood cell exchange to standard-of-care improves outcomes for adults with high-risk…
A $12.2-million grant awarded to the New York-based Mount Sinai Health System will enable a nationwide observational study to help…
To help heighten awareness of sickle cell disease (SCD) and pediatric cancers, while bringing comfort and relief to patients,…
A $1.9-million federal grant has been awarded to a clinical trial that seeks to find effective ways to improve adherence…
Because many individuals of African ancestry don’t know they have the sickle cell trait or what it means to be…
To help bring new therapies more quickly and cost effectively to those with sickle cell disease (SCD) in sub-Saharan…
A new, interactive application touted as the first of its kind can help people with sickle cell disease (SCD)…
Pfizer has decided to end a treatment discovery program with Syros Pharmaceuticals that it inherited after acquiring Global…
Genetic medicines company Scribe Therapeutics has expanded its collaboration with Sanofi to advance the development of a new…